Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure
1 University of California, San Francisco, Neurology, Suite 908, UCSF Multiple Sclerosis Center, 350 Parnassus Avenue, San Francisco, CA 94117, USA
2 University of California, San Francisco, Neurosurgery, 779M, 505 Parnassus Avenue, San Francisco, CA 94143, USA
Correspondence to:
Darin T Okuda, darin.okuda{at}ucsf.edu
We report a case of multifocal demyelination within the central nervous system in a patient being treated for a left hemispheric gemnistocytic astrocytoma with radiation therapy and chemotherapy, comprising temozolomide (360 mg/day—days 1–5 every 28 days) and 13-cis-retinoic acid (100 mg/m2/day—separated into two doses administered every 12 h on days 1 through 21 every 28 days). Five months into her first round of chemotherapy, brain magnetic resonance imaging (MRI) demonstrated multifocal regions of T2 prolongation with associated gadolinium enhancement within the right cerebral hemisphere. Spectroscopic data were consistent with demyelination rather than neoplasia. Despite the incidentally identified radiological progression, new neurological symptoms were not described. Interval resolution of the demyelinating lesions was observed in the years following the discontinuance of her chemotherapy regimen with reactivation of the previously observed lesions and the development of new T2 foci 6 months into her second round of re-treatment for tumour progression 5 years later.
Register for free content
The full text of all Editor's Choice articles and summaries of every article are free without registration
The full text of Images in ... articles are free to registered users
Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource
Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog
